SHR-1918 not checked

Hengrui

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
5 active
10 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Hypertriglyceridemia, Hyperlipidemia, Hypercholesterolemia, Homozygous Familial Hypercholesterolemia, Severe Hypertriglyceridemia With a High Risk of Acute Pancreatitis
Main trialPhase 3
“The purpose of the study is to evaluate the efficacy and safety of SHR-1918 in patients with hypertriglyceridemia. The efficacy and safety of SHR-1918 will be evaluated after 24-weeks and 48-weeks treatment.”In the company’s words, NCT07349615 on ClinicalTrials.gov

Other drugs for Hypertriglyceridemia

All 15 drugs for Hypertriglyceridemia

Coming up4

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials10

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Mar 2027 A Study of SHR-1918 In Participants With Hypertriglyceridemia
Phase 3Recruiting Oct 2027 A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Phase 2/3Recruiting Jul 2028 A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
Phase 2Not yet recruiting Dec 2025 Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Phase 2Active, not recruiting Jun 2027 Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis
Phase 3Completed 25 Aug 2025 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Phase 2Completed 29 Jun 2024 Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Phase 2Completed 16 May 2025 Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Phase 2Completed 4 Jul 2025 Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic
Phase 1Unknown 11 Dec 2023 Safety and Tolerability of SHR-1918 in Healthy Subjects
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow SHR-1918

Following is part of Solo: you see every change to SHR-1918 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in